Nancy Miller-Rich Buys 50,000 Shares of FDMT
Nancy Miller-Rich acquired 50,000 shares of FDMT on June 17, 2026.
Key Points
- Nancy Miller-Rich bought 50,000 shares of FDMT at no cost on June 17, 2026.
- FDMT shares are trading at $9.42 with peer activity showing both increases and reductions.
- Analysts from firms like Jefferies and RBC Capital maintain a buy rating on FDMT, with targets up to $36.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Nancy Miller-Rich recently acquired 50,000 shares of FDMT on June 17, 2026. The transaction was recorded at no cost per share, which is common in certain types of equity awards. This insider activity is often watched by investors for potential signals about the company's future.
Other Institutional Activity in FDMT
Several institutional investors have made notable changes to their FDMT holdings. Janus Henderson Group PLC increased its stake by 611,276 shares, ending with over 5.2 million shares valued at approximately $48.9 million. On the other hand, RA Capital Management, L.P. reduced its holdings by 603,432 shares, now holding just over 5 million shares worth about $47 million. Goldman Sachs Group Inc trimmed its position by 97,467 shares, leaving it with approximately 4.2 million shares valued at $39.2 million. Meanwhile, BlackRock, Inc. added 80,427 shares, bringing its total to about 4.1 million shares worth $38.6 million.
4D Molecular Therapeutics, Inc. Stock Down 35.8%
Shares of FDMT are currently trading around $9.42. The stock has experienced various adjustments by institutional investors, reflecting ongoing interest and activity in the market. While specific valuation metrics like P/E ratios are not provided, the trading price and peer activity offer some insight into the current market sentiment.
$FDMT stock price
Daily closing prices, year to date. Not investment advice.
Insider Buying and Selling at 4D Molecular Therapeutics, Inc.
In addition to Nancy Miller-Rich, several other insiders have also acquired shares of FDMT. On June 17, 2026, Charles Theuer, Glenn Sblendorio, Susannah Gray, John Milligan, and Jacob Chacko each bought 50,000 shares, with John Milligan purchasing 75,000 shares. These transactions were not part of any pre-planned trading program.
Analysts Set New Price Targets
FDMT has received positive attention from several analysts. On March 30, 2026, Jefferies assumed coverage with a buy rating and a price target of $21. Earlier, on March 20, 2026, HC Wainwright & Co. reiterated its buy rating with a target of $36. RBC Capital maintained its buy rating with a $35 target on March 19, 2026. These ratings suggest a bullish outlook among analysts.
Bottom Line
Insider purchases like those by Nancy Miller-Rich often attract attention as potential indicators of confidence in FDMT's future. The stock, trading at $9.42, has seen varying levels of interest from institutional investors and analysts alike. While 13F filings and insider transactions provide valuable insights, they are backward-looking and should be considered alongside other market factors.
Get 4D Molecular Therapeutics, Inc. alerts
New 13F filings, insider trades, and analyst moves on $FDMT, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.